GoHealth, Inc. (GOCO): Nasdaq/NYSE listing notice — GoHealth receives Nasdaq delisting notice for failure to meet $35M market value requirement

GoHealth, Inc.

Notice dated March 18, 2026 for non-compliance with MVLS Requirement (min $35M market value of listed securities).
Also fails alternative standards: stockholders' equity ≥$2.5M or net income from continuing ops of $500K.
180-day compliance period until September 14, 2026 to regain compliance.
No immediate effect on listing; common stock continues trading on Nasdaq under GOCO.
Company evaluating options to regain compliance, but no assurance of success.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

GoHealth, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5550(b)(1), 5550(b)(3)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5550(b)(2), 5550(b)(1), 5550(b)(3)

Exact text from the filing

March 18, 2026, GoHealth, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires listed companies on The Nasdaq Global Market to maintain a minimum market value of listed securities of $35 million (the “MVLS Requirement”). The Notice also indicates that the Company does not meet the alternative continued listing standards set forth in Nasdaq Listing Rules 5550(b)(1) and 5550(b)(3), which require listed

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

GoHealth, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-020176

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.